Investors & Media International Stem Cell Corporation Commences Trading on the OTCQX Best Market International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018 International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical Trial International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical Trial International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial International Stem Cell Corporation Raised Funds Through a Private Placement at Premium to Market International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program 1 2 3 4 5 6 7 << < > >>
